Clinical Trial Update: QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating QL1706 in combination with neoadjuvant chemotherapy followed by Type I hysterectomy for locally advanced cervical cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Neoadjuvant Immunotherapy, Locally Advanced Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING